Language

Medicine shortages: Belgium · Page 24

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 24 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 24

Belgium

Vitamine B12 Sterop 1 mg/1 ml or. sol./inj. sol. i.m./i.v./s.c. amp. 10 x 1 ml

Available again · Not specified
Active ingredient: Cyanocobalamin

Notice details →
Belgium

Vitamine D Sandoz 25 000 IU soft caps. 12

Available again · Not specified
Active ingredient: Cholecalciferol

Notice details →
Belgium

Xanax 1 mg (Impexeco) tabl. 50

Nicht verfügbar · Sonstige
Active ingredient: Alprazolam

Notice details →
Belgium

Xanax Retard 0.5 mg (Impexeco) tabl. prol.-rel. 30

Nicht verfügbar · Sonstige
Active ingredient: Alprazolam

Notice details →
Belgium

Xanax Retard 1 mg (Impexeco) tabl. prol.-rel. 30

Nicht verfügbar · Sonstige
Active ingredient: Alprazolam

Notice details →
Belgium

Zofran-Zydis 8 mg or. lyoph. 10

Nicht verfügbar · Manufacturing delay
Active ingredient: Ondansetron

Notice details →
Belgium

Amlodipine/Valsartan Krka 10 mg - 160 mg film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Valsartan,Amlodipine

Notice details →
Belgium

Annaïs Continu 0.02 mg - 3 mg film-coat. tabl. 3 x 28 (24 + 4)

Available again · Not specified
Active ingredient: Drospirenone ,Ethinylestradiol

Notice details →
Belgium

Bisoprolol Viatris 10 mg film-coat. tabl. 28

Marketing ended · Commercial reasons
Active ingredient: Bisoprolol Fumarate

Notice details →
Belgium

Bleomycine Hikma 15 000 IU inj. sol. (pwdr.) i.m./i.perit./i.tumor./i.v./i.pleur./i.arter./s.c. vial 15000 IU

Nicht verfügbar · Delay in final product release
Active ingredient: Bleomycin Sulfate

Notice details →
Belgium

Candesartan Krka 8 mg tabl. 98

Available again · Not specified
Active ingredient: Candesartan Cilexetil

Notice details →
Belgium

Cedocard 5 mg tabl. 60

Marketing ended · Sonstige
Active ingredient: Isosorbide Dinitrate

Notice details →
Belgium

Certican 0.5 mg tabl. 60

Nicht verfügbar · Manufacturing delay
Active ingredient: Everolimus

Notice details →
Belgium

Cosentyx 300 mg inj. sol. s.c. pre-filled pen 3 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Secukinumab

Notice details →
Belgium

Coveram 5 mg - 5 mg tabl. 90

Nicht verfügbar · Delay in final product release
Active ingredient: Amlodipine,Perindopril

Notice details →
Belgium

Duloxetine Krka 60 mg hard gastro-resist. caps. 28

Nicht verfügbar · Increased demand
Active ingredient: Duloxetine

Notice details →
Belgium

Duloxetine Viatris 30 mg hard gastro-resist. caps. 250

Marketing ended · Commercial reasons
Active ingredient: Duloxetine

Notice details →
Belgium

Enalapril/Lercanidipine Krka 10 mg - 10 mg film-coat. tabl. 98

Available again · Not specified
Active ingredient: Enalapril,Lercanidipine

Notice details →
Belgium

Etoricoxib AB 120 mg film-coat. tabl. 28

Nicht verfügbar · Sonstige
Active ingredient: Etoricoxib

Notice details →
Belgium

Fentanyl-Piramal 0.05 mg/ml inj. sol. i.m./i.v./s.c. amp. 30 x 2 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Fentanyl

Notice details →
Belgium

Fluoxetin AB 20 mg hard caps. 28

Nicht verfügbar · Sonstige
Active ingredient: Fluoxetine

Notice details →
Belgium

Irbesartan Viatris 300 mg tabl. 98

Marketing ended · Commercial reasons
Active ingredient: Irbesartan

Notice details →
Belgium

Lansoprazol KRKA 30 mg hard gastro-resist. caps. 56

Nicht verfügbar · Manufacturing delay
Active ingredient: Lansoprazole

Notice details →
Belgium

Lyrica 300 mg hard caps. 56

Available again · Not specified
Active ingredient: Pregabalin

Notice details →
Belgium

Melatonin Orifarm 2 mg film-coat. tabl. 30

Nicht verfügbar · Delay in final product release
Active ingredient: Melatonin

Notice details →
Belgium

Melatonin Orifarm 3 mg film-coat. tabl. 30

Nicht verfügbar · Delay in final product release
Active ingredient: Melatonin

Notice details →
Belgium

Metoprolol Retard Viatris 95 mg tabl. prol.-rel. 100

Marketing ended · Sonstige
Active ingredient: Metoprolol Tartrate

Notice details →
Belgium

Minims Fluorescein Sodium 20 mg/ml eye drops sol. single-dose cont. 20 x 0.5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Fluorescein Sodium

Notice details →
Belgium

Minitran 5 mg transderm. patch 30

Nicht verfügbar · Sonstige
Active ingredient: Glyceryl Trinitrate

Notice details →
Belgium

Oprymea 0.18 mg tabl. 100

Nicht verfügbar · Sonstige
Active ingredient: Pramipexole

Notice details →
Belgium

Optiray 350 mg I/ml (371 g/500 ml) inj. sol. i.arter. vial 500 ml

Available again · Not specified
Active ingredient: Ioversol

Notice details →
Belgium

Optiray 350 mg I/ml (74,2 g/100 ml) inj. sol. i.arter. vial 100 ml

Available again · Not specified
Active ingredient: Ioversol

Notice details →
Belgium

Pantoprazol Aurobindo 40 mg gastro-resist. tabl. 56

Nicht verfügbar · Sonstige
Active ingredient: Pantoprazole

Notice details →
Belgium

Perindopril/Amlodipine Krka 10 mg - 10 mg tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Amlodipine,Perindopril

Notice details →
Belgium

Perindopril/Indapamide Krka 10 mg - 2.5 mg tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Indapamide,Perindopril

Notice details →
Belgium

Pramipexole Viatris 0.7 mg tabl. 100

Marketing ended · Commercial reasons
Active ingredient: Pramipexole

Notice details →
Belgium

Quetiapine AB 150 mg tabl. prol.-rel. 100

Nicht verfügbar · Sonstige
Active ingredient: Quetiapine

Notice details →
Belgium

Sevikar 20 mg - 5 mg film-coat. tabl. 28

Nicht verfügbar · Manufacturing delay
Active ingredient: Olmesartan Medoxomil,Amlodipine

Notice details →
Belgium

Sevikar 40 mg - 5 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Olmesartan Medoxomil,Amlodipine

Notice details →
Belgium

Sitagliptine Krka 25 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Sitagliptin

Notice details →
Belgium

Solifenacin Krka 10 mg film-coat. tabl. 250

Nicht verfügbar · Manufacturing delay
Active ingredient: Solifenacin

Notice details →
Belgium

Solifenacin Krka 5 mg film-coat. tabl. 250

Nicht verfügbar · Manufacturing delay
Active ingredient: Solifenacin

Notice details →
Belgium

Tamsulosine EG 0.4 mg hard caps. modif.-rel. 200

Marketing ended · Replacement by another medicinal product/pack
Active ingredient: Tamsulosin Hydrochloride

Notice details →
Belgium

Thiosulfate de Sodium Sterop 1 g/5 ml inj. sol. i.v. amp. 100 x 5 ml

Nicht verfügbar · Sonstige
Active ingredient: Sodium Thiosulfate Pentahydrate

Notice details →
Belgium

Venlafaxine Retard AB 150 mg hard caps. prol.-rel. 28

Nicht verfügbar · Sonstige
Active ingredient: Venlafaxine

Notice details →
Belgium

Venlafaxine Retard AB 150 mg hard caps. prol.-rel. 56

Nicht verfügbar · Sonstige
Active ingredient: Venlafaxine

Notice details →
Belgium

Venlafaxine Retard AB 37.5 mg hard caps. prol.-rel. 28

Nicht verfügbar · Sonstige
Active ingredient: Venlafaxine

Notice details →
Belgium

Betahistine EG 24 mg tabl. 100

Marketing ended · Sonstige
Active ingredient: Betahistine Dihydrochloride

Notice details →
Belgium

Gambaran 500 mg film-coat. tabl. 60

Marketing ended · Commercial reasons
Active ingredient: Nabumetone

Notice details →
Belgium

Movicol 13.8 g or. sol. (pwdr.) sachet 20

Nicht verfügbar · Sonstige
Active ingredient: Sodium Chloride,Sodium Hydrogen Carbonate,Potassium Chloride,Macrogol

Notice details →